Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Biotech Revenues Grow By 20 Percent, Under Usual 30 Percent

This article was originally published in PharmAsia News

Executive Summary

India's biotechnology industry grew by 20 percent during 2007-2008, registering $2.56 billion in revenues. But BioSpectrum, which commissioned the biotech survey, said the appreciation of the Indian rupee and pricing pressures on exports, which account for more than half the sector's revenues, meant the one-year growth was short of the 30 percent annual growth the industry had registered for five consecutive years. A spokesman for BioSpectrum said, however, the current growth trend for the Indian industry bodes well for registering $13 billion to $16 billion in revenues by 2015. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts